PubMed · 2008 · 13 citations · 5 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyImmunopathologyImmunopharmacologyCorticosteroid TherapyImmunosuppressionInflammatory DermatosesInflammatory Skin DiseasesPyoderma GangrenosumSystemic Immunosuppressive TherapyTherapeutic CorticosteroidsTopical Corticosteroid PreparationsTreatment With Topical CorticosteroidsUlcerative DermatosesUlcerative InflammationUlcerative Skin Diseases
Pyoderma gangrenosum (PG) is an uncommon, chronic, painful, ulcerative skin disease of unknown origin, often associated with systemic diseases including inflammatory bowel disease, rheumatoid arthritis; monoclonal gammopathy, hepatitis and myeloproliferative disorders. The mainstay of therapy for PG has been high-dose corticosteroids but not all patients have a favourable outcome. Other systemic agents have also been used such as cyclosporine, azathioprine, cyclophosphamide and tacrolimus. However, all these systemic therapies can be complicated by serious side effects. In this paper, we report a series of four patients with pyoderma gangrenosum treated successfully with topical cyclosporine. No side-effects were observed in any of the patients and there was minimal systemic absorption of the topical cyclosporine.
5
PYODERMA (ECHTHYMA) GANGRENOSUM
Louis A. Brunsting · Archives of Dermatology · 1982 · 337 citations
Treatment of Pyoderma Gangrenosum With Cyclosporine
Wendy L. Matis · Archives of Dermatology · 1992 · 134 citations
Medicine, Dermatology, Pharmacology +16